Search
for
Sort by
Research 181–210 of 568
- Gender-Affirming Hormone Therapy for Transgender Females
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Becker's Nevus with Ipsilateral Breast Hypoplasia: Improvement with Spironolactone
- Novel agents for the treatment of alopecia
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Hidradenitis Suppurativa
- Androgen antagonists in androgen target tissues
- Post-finasteride syndrome: An emerging clinical problem
- Adverse health effects of androgen use
- Guidelines for the Use of Acitretin in Psoriasis
- Hormone therapy in acne
- Nutrition and the deleterious side effects of nutritional supplements
- Scalp Hair Regrowth in Hormone-Treated Transgender Woman
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Androgenetic alopecia; drug safety and therapeutic strategies
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Minoxidil overdose with ecg changes: Case report and review
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Skin diseases in consequence of endocrine alterations
- Therapeutic Androgen Receptor Ligands
- Post-finasteride syndrome
- 5-Alpha-Reductase Inhibitors and Combination Therapy